BrainStorm's NurOwn shows encouraging action in lung inflammation model Seeking Alpha, 23 Jul 2020 BrainStorm Cell Therapeutics (NASDAQ: BCLI ) announces encouraging results from a preclinical study assessing NurOwn (MSC-NTF…